This systematic review aims to synthesize current evidence on injectable anti-obesity therapies, comparing semaglutide, tirzepatide, and liraglutide regarding weight loss outcomes, metabolic benefits, and safety [1-5] (Figure 1)
For the best results, try to take it around the same time each day
These studies have shown significant weight loss and improvements in blood sugar control and cardiovascular risk factors
Thus, for example, as noted by the authors, in one study with liraglutide, obese subjects in the quartile of greatest weight loss had a mean weight loss of 18 kg with 3.0 mg of liraglutide compared with only 9 kg on placebo
As the body adapts, clinicians gradually increase the dose based on each individuals response